We have isolated a cDNA done encoding pancreatic polypeptide from a cDNA library constructed with RNA from an endocrine neoplasm of the human pancreas. The cDNA was inserted into plasmid pBR322 and the plasmid was Ala-Gln-Tyr-Ala of pancreatic polypeptide were used as hybridization probes. The pancreatic polypeptide cDNA isolated was 465 base pairs long and encoded a peptide of 95 amino acids in the coding region. The 36-amino acid sequence of pancreatic polypeptide was flanked by a 29-amino acid putative leader sequence at the amino terminus and a connecting tripeptide (Gly-Lys-Arg) followed by a 27-amino acid peptide at the carboxyl terminus. The first 20 of the amino acids in the carboxyl-terminal heptacosapeptide were identical to the structure of human pancreatic icosapeptide with the single exception of an isoleucine substitution for valine in the 18th position. This alteration results from an A-*G substitution in the nucleotide sequence of the cDNA and may represent a genetic variation or a point mutation in the pancreatic polypeptide cDNA.
Ala-Gln-Tyr-Ala of pancreatic polypeptide were used as hybridization probes. The pancreatic polypeptide cDNA isolated was 465 base pairs long and encoded a peptide of 95 amino acids in the coding region. The 36-amino acid sequence of pancreatic polypeptide was flanked by a 29-amino acid putative leader sequence at the amino terminus and a connecting tripeptide (Gly-Lys-Arg) followed by a 27-amino acid peptide at the carboxyl terminus. The first 20 of the amino acids in the carboxyl-terminal heptacosapeptide were identical to the structure of human pancreatic icosapeptide with the single exception of an isoleucine substitution for valine in the 18th position. This alteration results from an A-*G substitution in the nucleotide sequence of the cDNA and may represent a genetic variation or a point mutation in the pancreatic polypeptide cDNA.
Human pancreatic polypeptide is a 36-amino acid hormone that may be important in the regulation of pancreatic secretion and gall bladder relaxation (1) . As with other biologically active polypeptides, pancreatic polypeptide is thought to result from post-translational processing of a larger precursor form. In biosynthetic studies with dog pancreas, Schwartz and Tager (2) have found evidence that pancreatic polypeptide is cosynthesized with an icosapeptide that may represent a carboxyl-terminal extension of pancreatic polypeptide in the structure of its precursor. A homologous, but not identical, icosapeptide has been purified from human pancreas (3) . Recently, the structure of the pancreatic polypeptide precursor has been deduced from the nucleotide sequence of a cDNA clone obtained from human pancreatic tissue (4). The predicted structure confirms the presence of the icosapeptide in the carboxyl-terminal extension of pancreatic polypeptide. In the present paper, we report the independent construction from an endocrine tumor of a recombinant cDNA clone encoding pancreatic polypeptide. Our cDNA clone contained a variation in a single nucleotide, possibly representing a point mutation, which would result in an alteration in the amino acid sequence of the icosapeptide. 
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RESULTS
On colony hybridization with the pancreatic polypeptidespecific oligonucleotide probes, two transformants gave a positive signal, although only one of the clones could be harvested. By polyacrylamide gel electrophoresis, the cDNA insert in the plasmid appeared to be 480 base pairs in size, and it could be digested with restriction enzymes BamHI, Pvu II, Hinfl, Ava II, and Hpa II. The nucleotide sequence of the cloned cDNA and the corresponding deduced amino acid sequence of the pancreatic polypeptide precursor are depicted in Fig. 1 . According to this structure, the 36 amino acids comprising pancreatic polypeptide are preceded by a 29-amino acid putative leader sequence. There is a specific amino acid complex consisting of a glycine residue followed by two basic amino acids that follows the tyrosine that serves as the carboxyl-terminal amino acid of pancreatic polypeptide (position 36). The cDNA encoded a second peptide consisting of 27 amino acids, of which the first 20 are identical to the icosapeptide purified by Schwartz et al. (3) with the single exception that an A-*G substitution in the nucleotides encoding the 57th amino acid (position 18 in the icosapeptide) results in the replacement of a valine by an isoleucine residue. This alteration was confirmed as a T-*C substitution in the nucleotide sequence of the second cDNA strand (Fig. 2) . The translated region of the cDNA consists of 285 nucle- The cDNA synthesized by using the pancreatic polypeptidespecific oligonucleotide as a primer could be fractionated into eight major and numerous minor bands by polyacrylamide gel electrophoresis (Fig. 3) . Two of the major bands, nos. 5 and 2, were of 105 and 210 nucleotides, respectively. When the eight major labeled cDNAs were electroeluted from the polyacrylamide gels and used as detection probes, only cDNA 2 hybridized with the pancreatic polypeptide cDNA clone. Nevertheless, the nucleotide sequences of both cDNA 2 and cDNA 5 were determined. Although the nucleotide sequence of cDNA 2 exhibited a perfect match with the pancreatic polypeptide cDNA clone, that of cDNA 5 failed to exhibit any homology except in the specific region of the oligonucleotide primer. DISCUSSION In addition to its localization in healthy endocrine and exocrine pancreatic tissue, the frequent presence of pancreatic polypeptide in endocrine neoplasms has made it an occasionally useful tumor marker. The availability of one such tumor containing large amounts of pancreatic polypeptide has permitted us to isolate from a newly constructed cDNA library a recombinant clone encoding pancreatic polypeptide. As with the pancreatic polypeptide cDNA structure previously reported (4), the deduced amino acid sequence for the pancreatic polypeptide-encoding region is identical to the sequence reported for peptide purified by traditional biochemical techniques. Pancreatic polypeptide itself appears to be at the amino terminus of a 66-amino acid precursor that is preceded by a putative 29-amino acid hydrophobic leader sequence. Much in the manner observed for cDNA sequences of other carboxyl-terminally amidated peptides (9-12), a specific sequence of amino acids, glycine followed by two basic amino acid residues, appears to mark the cleavage site in the precursor for the formation of the amide moiety. Bradbury et al. (13) has postulated that the extended glycine moiety is converted to a carboxyl-terminal a-amide group by a process of dehydrogenation followed by hydrolysis of the resulting imino linkage.
The remaining peptide encoded by the pancreatic polypeptide cDNA clone is 27 amino acids long, the first 20 of which correspond to the pancreatic icosapeptide described by Schwartz et al. (3) . Since the carboxyl-terminal amino acid of the icosapeptide is arginine, it is possible that the icosapeptide is cleaved from the heptacosapeptide by a tryptic reaction as part of a post-translational processing mechanism or as an artifact of the extraction and isolation methods used in purification. The unique aspect of the cDNA clone that we isolated as compared with the pancreatic polypeptide cDNA clone isolated by Schwartz and co-workers (4) is that a single A-)G substitution in the translated region results in the substitution of an isoleucine moiety for valine in the deduced amino acid sequence of the icosapeptide. Since both isoleucine and valine are branchedchain hydrophobic amino acids, the amino acid substitution is a relatively conservative one. We cannot confirm from the present studies whether this observed alteration in nucleotide sequence represents a genetic variation or a true mutation, nor can we determine whether the alteration is present in the genetic structure of the patient's nonneoplastic tissue.
Potential difficulties in using peptide-specific oligonucleotides as cDNA primers or as hybridization probes are Proc. Natl. Acad Sci. USA 82 (1985) the possibilities that hybridization may occur despite basepair mismatches or that nonspecific hybridization may occur with incidental regions of homology. Noyes et al. (14) , using a dodecamer specific for hog gastrin, primed the synthesis of two cDNAs, only one of which encoded gastrin. Similarly, Chan et al. (15) primed the synthesis of two cDNAs using an insulin-specific decamer, but only one encoded insulin. Using conditions of relative stringency, we obtained at least eight cDNAs with our pancreatic polypeptide-specific oligonucleotides, but only one of them hybridized with the pancreatic polypeptide cDNA clone. We were able to identify that particular cDNA as being completely homologous with the pancreatic polypeptide cDNA, while at least one of the other cDNAs was homologous only in the region of the oligonucleotide primer.
In conclusion, we have isolated a cDNA clone encoding pancreatic polypeptide from a cDNA library constructed with RNA from an endocrine neoplasm. The nucleotide sequence of the clone exhibits an A-GG substitution that would result in an alteration in the deduced amino acid sequence of the icosapeptide region of the pancreatic polypeptide precursor. The physiological importance of this potential alteration awaits studies to determine the biological activity of the icosapeptide.
